Synthesis, characterization and anticancer activity of a Cd(II) complex with in situ formation of (E)-1-(5-chloro-2-hydroxy-benzylideneamino)-pyrrolidin-2-one ligand

被引:8
|
作者
Huang, Qiu-Ying [1 ]
Zheng, Ze-Bao [2 ]
Diao, Yun-Peng [3 ]
机构
[1] Henan Polytech Inst, Dept Chem Engn, Nanyang 473009, Peoples R China
[2] Taishan Univ, Coll Chem & Chem Engn, Tai An 271021, Shandong, Peoples R China
[3] Dalian Med Univ, Coll Pharm, Dalian 116044, Peoples R China
关键词
(E)-1-(5-chloro-2-hydroxybenzylideneamino)-pyrrolidin-2-one; In situ synthesis; Cadmium complex; Anticancer activity; COORDINATION POLYMERS; STRUCTURAL-CHARACTERIZATION; HYDROTHERMAL SYNTHESIS; BASE COMPLEXES; SCHIFF-BASES; AGENTS; DERIVATIVES; GENERATION; FRAMEWORKS; CHEMISTRY;
D O I
10.1016/j.molstruc.2015.02.022
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A new complex of Cd(II) with (E)-1-(5-chloro-2-hydroxybenzylideneamino)-pyrrolidin-2-one [Cd(L)(2)center dot 2DMF] was synthesized and characterized by elemental analysis, IR, TG and single-crystal X-ray diffraction. Where the HL ligand is formed in situ by the intramolecular nucleophilic substitution of (E)-N'-(5-chloro-2-hydroxybenzyli-dene)-4-(quinolin-8-yloxy)butanehydrazide (H2L'). The cadmium(II) ion is hexacoordinated by two tridentate L- ligands and giving a distorted octahedral coordination geometry. A cytotoxicity of [Cd(L)(2)center dot 2DMF] against liver (SMMC-7721) and cervical (HeLa) cancer cells have been studied. The results revealed that this cadmium(II) complex exhibited an effective and selective anticancer activity against HeLa over SMMC-7721 cell line with IC50 of 1.54 +/- 0.25 and 31.02 +/- 3.76 mu mol/dm(-3). (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
  • [1] Stereocontrolled synthesis of the enantiomers of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)-propyl]-pyrrolidin-2-one
    Kulig, K
    Holzgrabe, U
    Malawska, B
    TETRAHEDRON-ASYMMETRY, 2001, 12 (18) : 2533 - 2536
  • [2] Antioxidant activity and low toxicity of (E)-1-(1-(methylthio)-1-(selenopheny) hept-1-en-2-yl) pyrrolidin-2-one
    Rafael Porto Ineu
    Matheus dos Santos
    Olga Soares do Rêgo Barros
    Cristina Wayne Nogueira
    João Batista Teixeira Rocha
    Gilson Zeni
    Maria Ester Pereira
    Cell Biology and Toxicology, 2012, 28 : 213 - 223
  • [3] Antioxidant activity and low toxicity of (E)-1-(1-(methylthio)-1-(selenopheny) hept-1-en-2-yl) pyrrolidin-2-one
    Ineu, Rafael Porto
    dos Santos, Matheus
    do Rego Barros, Olga Soares
    Nogueira, Cristina Wayne
    Teixeira Rocha, Joao Batista
    Zeni, Gilson
    Pereira, Maria Ester
    CELL BIOLOGY AND TOXICOLOGY, 2012, 28 (04) : 213 - 223
  • [4] Crystal structure of 1-(E)- [(5-bromo-2-hydroxybenzylidene amino) pyrrolidin-2-one]: Design, synthesis and computational evaluation of a novel racetam congener for epilepsy
    Aiswarya, N.
    Rahul, C. N.
    Kothandan, Gugan
    Kurup, M. R. Prathapachandra
    Manoj, E.
    Chandrasekaran, P.
    Jeyaraman, Jeyakanthan
    Sekar, Kanagaraj
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1300
  • [5] Application of cyclic sulfates in the synthesis of enantiomers of 1-[3-(4-aryl-piperazin-1-yl)-2-hydroxy-propyl]-pyrrolidin-2-one
    Kulig, Katarzyna
    Boba, Agnieszka
    Bielejewska, Anna
    Gorska, Magdalena
    Malawska, Barbara
    TETRAHEDRON-ASYMMETRY, 2009, 20 (03) : 322 - 326
  • [6] Efficient iodine catalyzed three components domino reaction for the synthesis of 1-((phenylthio)(phenyl)methyl)pyrrolidin-2-one derivatives possessing anticancer activities
    Ramachandran, Gunasekar
    Karthikeyan, Natesan S.
    Giridharan, Periyasamy
    Sathiyanarayanan, Kulathu I.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (28) : 5343 - 5346
  • [7] Iodine catalyzed three component synthesis of 1-((2-hydroxy naphthalen-1-y1)(phenyl)(methyl))pyrrolidin-2-one derivatives: Rationale as potent PI3K inhibitors and anticancer agents
    Muralidharan, Vivek Panyam
    Alagumuthu, Manikandan
    Iyer, Sathiyanarayanan Kulathu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (11) : 2510 - 2514
  • [8] Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and α-adrenolytic activity
    Kulig, Katarzyna
    Sapa, Jacek
    Maciag, Dorota
    Filipek, Barbara
    Malawska, Barbara
    ARCHIV DER PHARMAZIE, 2007, 340 (09) : 466 - 475
  • [9] Synthesis of the enantiomers of 1-{2-hydroxy-3-[4-(2-hydroxy-phenyl)-piperazin-1-yl]-propyl}-pyrrolidin-2-one using soluble and polystyrene bound salenCo(III)OAc complexes as catalysts of hydrolytic kinetic resolution
    Kulig, K.
    Nowicki, P.
    Malawska, B.
    POLISH JOURNAL OF CHEMISTRY, 2007, 81 (02) : 179 - 186
  • [10] Synthesis, crystal structure, and biological activity of 4′-chloro-2,2′: 6′,2"-terpyridine (Cltpy) as tridentate ligand in a Cd(II) complex
    Saghatforoush, L. A.
    Valencia, L.
    Chalabian, F.
    Ghammamy, S.
    Khaledi, L. Z.
    JOURNAL OF COORDINATION CHEMISTRY, 2011, 64 (19) : 3311 - 3322